The BioButton was supposed to send them back to college safely. But concerns over the mandatory wearable’s data collection practices led to a student petition—and a school reversal. Last week, Oakland ...
UCHealth's staff and providers will wear the BioButton device for two days prior and seven days following a COVID-19 vaccine dose to detect potential adverse vital sign trends. Together with a daily ...
BioIntelliSense has received approval from the US Food and Drug Administration (FDA) for its BioButton Multi-Patient wearable and BioDashboard system for continuous patient monitoring. The ...
DENVER, March 15, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense , a continuous health monitoring and clinical intelligence company, expands its commitment to creating a new standard of remote patient care ...
Medtronic plc MDT recently formed a strategic partnership with BioIntelliSense for the exclusive U.S. hospital and 30-day post-acute hospital to home distribution rights of the BioButton ...
DUBLIN, Aug. 31, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has entered into a strategic partnership with BioIntelliSense, a continuous ...
BioIntelliSense's new BioButton for 90-days of continuous wireless temperature and vital signs monitoring on a coin-sized disposable medical device. (BioButton) Oakland University will require ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results